-
Chongqing Kangke company's Ergrememy tablets 1mg successfully passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2020-06-09
according to the According to the International Diabetes Federation, the number of people with diabetes in China reached 114.4 million (20-79 years old) in 2017, the highest number in the world It is
-
France's Valbiotis announces positive top-line data for Valedia IIA clinical study
Time of Update: 2020-06-09
recently, (http:// of Valbiotis , France, published positive top-line data for clinical studies in Valedia (active ingredient: TOTUM-63) IIA the study, conducted in people with prediabetes, asses
-
New anti-AIDS drug Selavino developed by Chinese scientists has been approved by China's State Drug Administration for clinical trials
Time of Update: 2020-06-09
Recently, the of the of the Anti-AIDS New Drug (http:// developed by the Shanghai Medicines (http:// ) Research Institute of the Chinese Academy of Sciences and the Institute agreed to conduct
-
FDA accepts new drug application for opicapone
Time of Update: 2020-06-09
The U.S Food and Drug (http:// Administration ( FDA (http:// has accepted new drug (http:// application (NDA), Neurocrine Biosciences announced Opicapone is a new, daily, oral selective cat
-
Azurity's quasi-Katerzia oral fluid is approved by the U.S. FDA
Time of Update: 2020-06-09
recently, The u.S Food and Drug (http:// Administration ( FDA (http:// has approved Katerzia (amlodiodia, 1mg/mL) oral fluid (1mg/mL) for the treatment of hypertension in children and adults
-
FDA approves listing of Pfizer biosimilar Zirabev-bvzr
Time of Update: 2020-06-09
recently, Pfizer announced that it The FDA (http:// approved the listing of its biosimilar, Zirabev-bvzr about Zirabev Zirabev is a biosimilar to the heavy anticancer drug (http:// bevacizum
-
Rohingya Pharmaceuticals cephalosporine capsules approved by the State Drug Administration
Time of Update: 2020-06-09
recently, Shandong Luoxin Pharmaceutical Group Limited Company (http:// (hereinafter referred to as "Roxin Pharmaceuticals") cephalosporine capsules were approved by the State Pharmaceutical (h
-
Qilu Pharmaceuticals myeloma drug to nale amine "Chipyi" officially listed
Time of Update: 2020-06-09
multiple Myeloma (MM) is a malignant blood tumor in which plasma cells proliferate abnormally in the bone marrow, which occurs in middle-aged and elderly people, with typical symptoms such as bone p
-
European Commission approves Dovato for treatment of HIV-1 infections in adolescents and adults
Time of Update: 2020-06-09
recently, http:// The European Commission (EC) has approved Dovato (dolutegravir/lamivudine, DTG/3TC, 50mg/300mg tablets ) for the treatment of adolescents over the age of 12 who weigh s40kg and ar
-
European Commission approves Ultomiris ® (ravulizumab) for treatment of adult patients with haemoglobinuria
Time of Update: 2020-06-09
recently, Alexion Pharmaceuticals announced that the European Commission has approved the Ultomiris ® for the treatment of adult patients with haemoglobinuria on the of Ultomiris Ultomiris is a l
-
FDA accepts new drug application for new kiozanimod for recurrent multiple sclerosis
Time of Update: 2020-06-09
recently, Celgene announced that the Us FDA (http:// has accepted the application for new drug (http:// (NDA) for the treatment of recurrent multiple sclerosis (RMS), and the European Medicin
-
MHLW approves Alexion's Ultomiris (ravulizumab) for treatment of PNH adult patients
Time of Update: 2020-06-09
recently, Alexion company (http:// announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Ultomiris (ravulizumab) for the treatment of adult patients with haemoglobinuria (
-
Xi'an Yangsen Zhaoxuan ® (Daretoyu mono-anti-injection) approved by the State Drug Administration
Time of Update: 2020-06-09
recently, Johnson and Johnson Company (http:// in China Pharmaceutical (http:// subsidiary Xi'an Yangsen Pharmaceutical Co., Ltd announced that its mega-® (Daretoyu mono-resistant injection) h
-
Bayer announces FDA approval for its Gadavist injection
Time of Update: 2020-06-09
Recently, Bayer announced that the U.S FDA (http:// has approved Gadavist injections for cardiac magnetic resonance imaging (CMRI) for the evaluation of myocardial perfusion and advanced radon en
-
Kanghong Pharmaceuticals' oral solution of Aliquin has been approved by the State Drug Administration
Time of Update: 2020-06-09
recently, Kanghong Pharmaceuticals announced that the of the Company (http:// received the "Drug Registration Approval" (batch number: 2019S00438) issued by the State Medicines (http:// Regula
-
A supplementary biologics license from Roche Rituxan is accepted by the FDA
Time of Update: 2020-06-09
GPA and MPA are two types of ANCA-associated vasculitis (AAV) AAV is an vasculitis that mainly affects small blood vessels In general, GPA and MPA affect small blood vessels in the kidneys, lungs, si
-
FDA grants AstraZeneca's orphan drug for small cell lung cancer
Time of Update: 2020-06-09
AstraZeneca, the pharmaceutical (http:// giant, announced that the Authority for food and drugs (http:// ( ) of the FDA (http:// had granted the PD-L1 tumor immunotherapy Imfinzi (SCLC) to tr
-
FDA approves Vyndaqel and Vyndamax capsules for the treatment of ATTR-CM
Time of Update: 2020-06-09
recently, the United States The FDA (http:// approved The Tafamidis Meglumine and Tafamidis capsules for the treatment of transthyroxinelobin myocardial disease (ATTR-CM) this is an FDA-approved
-
GSK announces phase III clinical study targeting cancer drug Zejula for patients with advanced ovarian cancer reaches major end point
Time of Update: 2020-06-09
GlaxoSmithKline (GSK), the uk's pharmaceutical (http:// , recently announced that the evaluation of the targeted anti-cancer drug Zejula (Chinese brand name: Seile, generic name: niraparib, Nirapa
-
NMPA approves Lilly Elamine ® (Barretini tablets) 2mg tablets for the treatment of severe active rheumatoid arthritis in adults
Time of Update: 2020-06-09
rheumatoid arthritis is a chronic inflammatory autoimmune disease that seriously affects the daily work and life of patients, thus affecting their quality of life Recent epidemiological surveys show